格隆汇11月20日｜人民同泰(600829.SH)早盘一度跌停，现跌9.72%报14.4元，总市值83.5亿元；此前11月10日至17日，该股录得6连板涨停。人民同泰公告 称，控股股东哈药集团股份有限公司持有公司股份433,894,354股，占公司总股本的74.82%，因经营需要，计划自公告披露之日起15个交易日后的3个月内， 通过集中竞价交易方式减持不超过579.88万股的公司股份，占公司总股本比例不超过1%。减持期间为2025年12月11日至2026年3月10日。(格隆汇) ...

Core Viewpoint - People's Tongtai (600829) has experienced a significant decline in stock price, hitting the limit down at 14.36 CNY per share, with a drop of 9.97%, marking two consecutive trading days of limit down [1] Group 1: Stock Performance - People's Tongtai's stock price surged prior to the recent decline, achieving six consecutive days of gains from November 10 to November 17 [1] Group 2: Shareholding Changes - The controlling shareholder, Harbin Pharmaceutical Group, announced plans to reduce its stake in People's Tongtai by up to 5.7988 million shares, which represents no more than 1% of the company's total share capital, through centralized bidding within three months starting from 15 trading days after the announcement [1]

（文章来源：每日经济新闻） 每经AI快讯，11月20日，人民同泰跌停走出2连板，2天累计跌幅达18.96%。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:600664 证券简称:哈药股份编号:2025-051 哈药集团股份有限公司 十届二十一次董事会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性承担法律责任。 哈药集团股份有限公司（以下简称"公司"）第十届董事会第二十一次会议以书面方式发出通知，于2025 年11月19日以通讯表决方式召开。会议应参加董事9人，实际参加董事9人。会议召开符合《中华人民共 和国公司法》和《公司章程》的有关规定，会议审议通过了《关于减持公司所持控股子公司部分股份的 议案》（同意9票，反对0票，弃权0票）。 经审议，公司董事会同意授权公司管理层从维护公司股东及公司的利益出发，根据证券市场情况择机减 持公司所持哈药集团人民同泰医药股份有限公司（证券代码：600829，以下简称"人民同泰"）股份，授 权内容包括但不限于时机、价格、数量等，授权期限自董事会审议通过至上述授权事项处理完毕之日 止。 具体内容详见公司同日在上海证券交易所网站（www.sse.com.cn）披露的《哈药集团股份有限公司关于 减持 ...

Key Points - 合富中国's stock will resume trading on November 20 after completing an investigation into unusual trading fluctuations, confirming normal business operations and no undisclosed significant matters [1] - 中金公司 plans to merge with 东兴证券 and 信达证券, leading to a suspension of its A-shares starting November 20 due to uncertainties surrounding the merger [1] - 大为股份 is progressing with the transition from exploration to mining rights for its lithium battery project in Hunan, having received necessary approvals [1] - 燕东微's major shareholders plan to reduce their stakes by up to 2.5% through block trades or centralized bidding from December 11, 2025, to March 11, 2026 [2] - 中水渔业's major shareholder reduced its stake to 5% after selling 258.88 million shares [3] - 韵达股份 reported a slight decline in express service revenue for October 2025, totaling 4.495 billion yuan, a year-on-year decrease of 0.88% [4] - 倍杰特 intends to acquire a 55% stake in 大豪矿业 for 224.8 million yuan [4] - 辰奕智能 plans to acquire a 55% stake in 华泽电子 through cash [4] - 赣粤高速's actual controller will change from the provincial transportation department to the provincial state-owned assets supervision and administration commission [5] - 东软集团 received a notification for a 4.2 billion yuan contract for intelligent cockpit controllers from a major domestic automotive manufacturer [5] - 海正药业's subsidiary plans to invest in a pet prescription food project [5] - 龙利得's controlling shareholder plans to increase its stake by at least 56 million yuan [6] - 新兴装备's shareholders plan to reduce their stakes by up to 3.13% [6] - 普洛药业 plans to repurchase shares worth between 180 million and 360 million yuan [6]

Group 1: Company Buybacks - Longlide plans to repurchase company shares for no less than 56 million yuan [2] - Hanshuo Technology has obtained a commitment letter for a stock repurchase loan from a financial institution [2] - Prolo Pharmaceutical intends to use between 180 million to 360 million yuan to buy back company shares [2] Group 2: Company Sell-offs - Suda Co., Ltd. plans to reduce its holdings by no more than 3% [2] - Hunan Baiyin intends to reduce its holdings by no more than 1.95% [2] - Zimi Co., Ltd. plans to reduce its holdings by no more than 1% [2] - Zhongshui Fishery's third-largest shareholder has reduced its holdings by 2.5888 million shares, bringing its stake down to 5% [2] - We Online's investors plan to collectively reduce their holdings by no more than 5.94% [2] - Renmin Tongtai's controlling shareholder plans to reduce its holdings by no more than 1% [2] - Yanshiwei's fourth and fifth largest shareholders plan to reduce their holdings by no more than 1.5% and 1% respectively [2] - Langke Intelligent's shareholders plan to reduce their holdings by no more than 1.68% [2] - Yingben Co., Ltd.'s director plans to reduce his holdings by no more than 0.03% [2] - Sunshine Power has completed the implementation of share reduction plans by some directors and senior management [2] - Dipu Technology's shareholder plans to reduce his holdings by no more than 1.55% [2] - MediWest's shareholder plans to reduce his holdings by no more than 1.64% [2] - Huahai Qingke's shareholder plans to reduce his holdings by no more than 1% [2] - Liyuan Technology's shareholder plans to reduce his holdings by no more than 2.0303% [2] - New Emerging Equipment's shareholders plan to collectively reduce their holdings by no more than 3.13% [2] - Jinqiao Information's director plans to reduce his holdings by no more than 0.0675% [2] - Kanglongda's shareholder plans to reduce his holdings by no more than 3% [2]

格隆汇11月19日丨人民同泰(600829.SH)公布，控股股东哈药股份根据经营需要，计划自本公告披露之 日起15个交易日后的3个月内，拟通过集中竞价交易方式减持公司股份，拟减持股份数量不超过579.88 万股，占公司总股本的比例不超过1%。哈药股份将结合市场情况、股价表现以及相关规定等因素，决 定是否实施以及如何实施本次股份减持计划，实际减持数量和减持价格存在不确定性。 ...

值得一提的是，近期人民同泰股价大涨，于11月10日至17日斩获六连板。不过，11月19日，人民同泰以 跌停收盘，收于跌停价15.95元/股，跌幅为9.99%。 北京商报讯（记者 丁宁）11月19日晚间，人民同泰（600829）发布公告称，公司控股股东哈药股份根 据经营需要，计划自公告披露之日起15个交易日后的3个月内，拟通过集中竞价交易方式减持公司股 份，拟减持股份数量不超过579.88万股，占公司总股本的比例不超过1%。 ...

证券代码：600829 证券简称：人民同泰 公告编号：2025-035 哈药集团人民同泰医药股份有限公司 控股股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 控股股东持股的基本情况：截至本公告披露日，哈药集团人民同泰医药 股份有限公司（以下简称"公司"）控股股东哈药集团股份有限公司（以下简称 "哈药股份"）持有公司股份 433,894,354 股，占公司总股本的 74.82%。股份来 源为重大资产重组及其他方式。 | 股东名称 | 哈药集团股份有限公司 | | --- | --- | | 计划减持数量 | 不超过：5,798,800 股 | | 计划减持比例 | 不超过：1% | | 减持方式及对应减持数量 | 集中竞价减持，不超过：5,798,800 股 | | 减持期间 | 2025 年 12 月 11 日～2026 年 3 月 10 日 | | 拟减持股份来源 | 其他方式取得 | | 拟减持原因 | 股东经营需要 | 预披露期间，若公司股票发生停牌情形的，实际开始减持的时 ...

人民财讯11月19日电，人民同泰（600829）11月19日公告，公司控股股东哈药股份（600664）拟通过集 中竞价交易方式减持公司股份不超过579.88万股，占公司总股本的比例不超过1%。 ...